|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Current tax receivable | |||||
| Other assets | |||||
| Receivables, net | |||||
| Investments in receivables, net | |||||
| Credit card receivables | |||||
| Property, plant and equipment, net | |||||
| Other intangible assets, net | |||||
| Goodwill | |||||
| Total Assets | |||||
| Liabilities and Stockholder's Equity | |||||
| Liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Other liabilities | |||||
| Current tax liabilities | |||||
| Deferred tax liabilities | |||||
| Notes payable, net | |||||
| Total Liabilities | |||||
| Stockholders' Equity | |||||
| Common Stock par value $0.0001 per share; 330,000,000 shares authorized as of June 30, 2026 and December 31, 2025 and 57,435,586 and 58,298,923 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||
| Additional paid-in capital | |||||
| Retained earnings | |||||
| Accumulated other comprehensive income (loss) | |||||
| Total stockholders' equity | |||||
| Total Liabilities and Stockholders' Equity |
Loading...
